Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.
Press releases published on June 6, 2025
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
Spur Therapeutics Presents Positive New Preclinical Data on Its Gene Therapy Candidate for GBA1 Parkinson’s Disease at 2025 GBA1 Meeting
GlobeNewswire
·
June 6, 2025
Data show SPR301 lowered α-synuclein, a hallmark of Parkinson’s disease, in cellular models, indicating potential for efficacy at doses with favorable safety Demonstrated greater α-synuclein reductions compared to other gene therapy approaches LONDON, June …
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
GlobeNewswire
·
June 6, 2025
New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or minimal itch with ZORYVE cream 0.15% or ZORYVE cream 0. …
American Rebel CEO to Perform at Bristol Dragway and American Rebel Light Beer to be Featured at Trackside Bar and Beer Garden
GlobeNewswire
·
June 6, 2025
PATRIOTISM MEETS HORSEPOWER: ANDY ROSS TO IGNITE BRISTOL DRAGWAY WITH ELECTRIFYING PERFORMANCE! NASHVILLE, TN, June 06, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on June …
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 6, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference, …
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
GlobeNewswire
·
June 6, 2025
– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine – – VERITAC-2 …
BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries
GlobeNewswire
·
June 6, 2025
RESEARCH TRIANGLE PARK, N.C., June 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that, following a positive recommendation from the Zorginstituut Nederland, ORLADEYO® (berotralstat) has been approved for the …
At Neudata Summit, MoonFox Data Presents AI + Alternative Data Solutions, Empowering Global Institutions to Decode China's Market
GlobeNewswire
·
June 6, 2025
SHENZHEN, China, June 06, 2025 (GLOBE NEWSWIRE) -- MoonFox Data, China’s leading provider of all-scenario data insights and analytics services, was recently invited to deliver a keynote address at the Neudata Hong Kong Data Summit 2025, held at the Hong …
Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression
GlobeNewswire
·
June 6, 2025
- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo’s CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 (liafensine) in treatment-resistant depression (TRD) - SAN …
Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)
GlobeNewswire
·
June 6, 2025
SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …
Lucinity Appoints Payoneer CCO and Goldman Sachs MD as Strategic Advisors
GlobeNewswire
·
June 6, 2025
REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) -- Lucinity has expanded its Advisory Council with the appointment of industry leaders Micheal Sheehy, Chief Compliance Officer at Payoneer, and Konstantinos Rizakos, Managing Director of Compliance …
Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025
GlobeNewswire
·
June 6, 2025
Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate (PPi) efflux via on-target engagement of the ABCC6 …
Polpharma Group soutient l’action urgente de l’UE visant à garantir l’accès aux médicaments et à renforcer la souveraineté pharmaceutique européenne
GlobeNewswire
·
June 6, 2025
AMSTERDAM, 06 juin 2025 (GLOBE NEWSWIRE) -- Polpharma Group, fabricant européen de produits pharmaceutiques de premier plan, s’est joint aux autres membres de l’association Medicines for Europe pour signer une lettre ouverte adressée aux Premiers ministres …
Die Polpharma Group unterstützt dringende Maßnahmen der EU zur Sicherung des Zugangs zu Arzneimitteln und zur Stärkung der pharmazeutischen Souveränität Europas
GlobeNewswire
·
June 6, 2025
AMSTERDAM, June 06, 2025 (GLOBE NEWSWIRE) -- Die Polpharma Group, ein führender europäischer Pharmahersteller, hat sich anderen Mitgliedern von Medicines for Europe angeschlossen und einen offenen Brief an die Premierminister und Gesundheitsminister aller …
クラウデラ (Cloudera)、AI-RANアライアンスに加盟し、リアルタイムデータの革新とAIネイティブな通信分野の発展を推進
GlobeNewswire
·
June 6, 2025
カリフォルニア州サンタクララ発, June 06, 2025 (GLOBE NEWSWIRE) -- データ、分析、AIのための唯一の真のハイブリッドプラットフォームであるクラウデラは本日、AIを通信インフラに統合することを目的とした国際的なコンソーシアムであるAI-RANアライアンスに加盟したことを発表した。 クラウデラは、AI-RANの推進と、通信ネットワークをリアルタイムデータとAIによって知能化された収益創出型プラットフォームへと変革することを目的に、データとAI …
Cloudera, 실시간 데이터 혁신 및 AI 네이티브 통신 추진을 위해 AI-RAN Alliance에 합류
GlobeNewswire
·
June 6, 2025
산타클라라, 캘리포니아, June 06, 2025 (GLOBE NEWSWIRE) -- 데이터, 애널리틱스, AI 활용을 위한 하이브리드 유일 플랫폼 Cloudera가 통신 인프라에 AI 통합을 추진 중인 글로벌 컨소시엄인 AI-RAN Alliance에 가입했다고 오늘 발표했다. Cloudera는 AI-RAN 어젠다를 추진하는 한편 통신 네트워크를 실시간 데이터와 AI를 통해 지능형 수익 창출 플랫폼으로 전환하는 데 주력하는 데이터 및 AI 관련 기업들과 …
Cloudera Menyertai AI-RAN Alliance untuk Mendorong Inovasi Data Masa Nyata dan Telekomunikasi Berasaskan AI
GlobeNewswire
·
June 6, 2025
SANTA CLARA, California, June 06, 2025 (GLOBE NEWSWIRE) -- Cloudera, satu-satunya platform hibrid sebenar untuk data, analitik dan AI, hari ini mengumumkan penyertaannya dalam AI-RAN Alliance, sebuah konsortium global yang komited untuk mengintegrasikan AI …
Cloudera 加入 AI-RAN Alliance，驱动实时数据创新与 AI 原生通信
GlobeNewswire
·
June 6, 2025
圣克拉拉，加利福尼亚州, June 06, 2025 (GLOBE NEWSWIRE) -- 唯一真正的数据、分析和 AI 混合平台 Cloudera 今日宣布其已加入致力于将 AI 融入电信基础设施的全球联盟 AI-RAN Alliance。 Cloudera 将成为这一开创性创新电信服务商团队中的一员，与数据及 AI 企业共同致力于推动 AI-RAN 议程，通过实时数据与 AI 将电信网络转型为智能创收平台。 随着电信服务商竞相利用虚拟化以及下一代基础设施和架构优化网络运营成本，AI …
Cloudera 加入 AI-RAN 聯盟推動實時數據創新和 AI 原生電訊
GlobeNewswire
·
June 6, 2025
聖塔克拉拉，加州, June 06, 2025 (GLOBE NEWSWIRE) -- 唯一真正混合數據、分析和人工智能 (AI) 的平台 Cloudera，於今天宣佈已加入 AI-RAN Alliance；AI-RAN Alliance 是一個全球性聯盟，致力於將 AI 整合到電訊基礎設施中。 Cloudera 與一群開創性的創新電訊提供商，與數據和 AI 公司攜手合作，專注於推動 AI-RAN 目標，將電訊網絡轉換為利用實時數據和 AI 的智能化、產生收入的平台。 …